Abstract: A titanium dioxide micro-nanocontainers, corrosion-resistant waterborne epoxy coatings and preparation method thereof, including preparation steps as follows: TiO2 micro-nano spheres are synthesized by applying hydrothermal method; a polyaniline layer doped with molybdate ions is deposited on the surface of TiO2 micro-nano spheres by adopting the method of in-situ chemical polymerization, TiO2/PANI-MoO42? micro-nano-spheres are obtained, then, polydopamine is encapsulated on the surface of TiO2/PANI-MoO42? micro-nano spheres to obtain titanium dioxide micro-nanocontainers; next, antirust filler, defoamer, dispersant and thickener are added into waterborne epoxy emulsion, then titanium dioxide micro-nanocontainers are added in the waterborne epoxy emulsion for dispersing and grinding, filtering and encapsulating to obtain component A; the waterborne epoxy curing agent and deionized water are mixed in proportion to obtain component B; component A is stirred, then it is mixed with the component B in proportion,

Abstract: The present disclosure provides a kit and method for constructing a long-acting depression animal model. The present disclosure adopts Bacille Calmette-Guerin (BCG) (or Mycobacterium bovis (M bovis)) and low-dose pertussis toxin (PTX) for combined induction, which greatly reduces modeling cost. A mouse model constructed by the method of the present disclosure can clearly distinguish a time interval of pathological behaviors from a time interval of depression-like behaviors and has prominent face validity and predictive validity. The method of the present disclosure is simple and convenient and does not require a large number of tedious daily operations as the depression model construction by chronic unpredictable stress, chronic restraint stress, social defeat, mother-child separation, or the like. The mouse model of the present disclosure can provide a valuable long-term intervention window for research on antidepressant therapy.

Abstract: Embodiments of this application provide a testing apparatus, configured to test a battery and including a test body and a first door body. The test body may include an accommodating cavity for accommodating the battery, and an opening. The opening may communicate with the accommodating cavity, and the first door body may be connected to the opening and capable of moving relative to the opening. The first door body may have a first state and a second state; in the first state, the first door body may block a part of the opening; and in the second state, the first door body may seal the opening.

Abstract: One aspect of the disclosure relates to the use of derivatives of dichlorophenyl urea for treating cancers.

Abstract: The extraction system contains secondary amides and alkyl alcohols which are separately used as the extractants for extracting lithium and boron and consist of a single compound or a mixture of two or more compounds, and the total number of carbon atoms in their molecules are 12˜18 and 8˜20 respectively; the extraction system has a freezing point less than 0° C. With a volume ratio of an organic phase and a brine phase being 1˜10:1, at a brine density of 1.25˜1.38 g/cm3, at a brine pH value of 0˜7 and at a temperature of 0˜50° C., a single-stage or multi-stage countercurrent extraction and a stripping are conducted to obtain a water phase with a low magnesium-lithium ratio, which is subjected to concentration, impurity removal and preparation to get lithium chloride, lithium carbonate, lithium hydroxide and boric acid respectively. Water is used for stripping, greatly reducing the consumption of acid and base.

Abstract: The secondary amide contained in the extraction system consists of a single compound or a mixture of two or more compounds, wherein R1 is selected from a C2˜C12 alkyl, or a C3˜C12 cycloalkyl containing a single-ring structure, R2 is selected from a C1˜C11 alkyl, or a C3˜C11 cycloalkyl containing a single-ring structure; the total number of carbon atoms in the molecule is 12˜18. With a volume ratio of an organic phase and a brine phase being 1˜10:1, at a brine density of 1.25˜1.38 g/cm3 and at a temperature of 0˜50° C., a single-stage or multi-stage countercurrent extraction and a stripping are conducted to obtain a water phase with a low magnesium-lithium ratio, which is subjected to concentration, impurity removal and preparation to get lithium chloride, lithium carbonate and lithium hydroxide respectively. Water is used for stripping, greatly reducing the consumption of acid and base, and the separation process is shortened.

Abstract: One aspect of the disclosure relates to the use of derivatives of dichlorophenyl urea for treating cancers.

Abstract: An ultra-low power consumption power supply structure, comprising: a first LDO circuit, a second LDO circuit, a first Bandgap module, a second Bandgap module and a switching circuit, wherein the first LDO circuit is used for providing an LDO output voltage when an SOC chip is in a normal operating mode, and the second LDO circuit is used for providing an LDO output voltage when the SOC chip is in an ultra-low power consumption mode; the first Bandgap module is used for providing, based on a main power supply voltage, a first reference voltage for the first LDO circuit at the time of power-on startup, and the second Bandgap module is used for providing a second reference voltage for the second LDO circuit after power-on startup is completed; and the switching circuit is used for switching the mode in which the first reference voltage is output by the first Bandgap module at the time of power-on startup to the mode in which the second reference voltage is output by the second Bandgap module after power-on start

Abstract: An ultra-low power consumption power supply structure, comprising: a first LDO circuit, a second LDO circuit, a first Bandgap module, a second Bandgap module and a switching circuit, wherein the first LDO circuit is used for providing an LDO output voltage when an SOC chip is in a normal operating mode, and the second LDO circuit is used for providing an LDO output voltage when the SOC chip is in an ultra-low power consumption mode; the first Bandgap module is used for providing, based on a main power supply voltage, a first reference voltage for the first LDO circuit at the time of power-on startup, and the second Bandgap module is used for providing a second reference voltage for the second LDO circuit after power-on startup is completed; and the switching circuit is used for switching the mode in which the first reference voltage is output by the first Bandgap module at the time of power-on startup to the mode in which the second reference voltage is output by the second Bandgap module after power-on start

Abstract: The present invention discloses a method for producing lithium carbonate from a low-lithium brine by separating magnesium and enriching lithium. A salt-lake brine is used as a raw material and is converted into halide salts through dehydration by evaporation and separation by crystallization; the halide salts are directly extracted using trialkyl phosphate or a mixture of trialkyl phosphate and monohydric alcohol, and an organic extraction phase as well as remaining halide salts are obtained after solid-liquid separation; reverse extraction is performed on the organic extraction phase to obtain a lithium-rich solution with a low magnesium-to-lithium ratio, and lithium carbonate is obtained after concentration and removal of magnesium by alkalization. The used solid-liquid extraction method is simple with no co-extraction agent used, and a solute distribution driving force is strong, unaffected by phase equilibrium of the brine extraction agent.

Abstract: One aspect of the disclosure relates to derivatives of aryl and heterocyclic ureido aryl and heterocyclic carboxamido isobutyric acids, dichlorophenyl urea, curcumin, and 1,3-diazetidine-2,4-dione, and pharmaceutical compositions thereof. The derivatives disclosed herein can modulate development of adipocytes and various cancer cells, including resistant cancer cells and cancer stem cells. Another aspect of the disclosure relates to the use of the derivatives and pharmaceutical compositions disclosed herein in treatment of obesity and various cancers.

Abstract: The present invention discloses a method for producing lithium carbonate from a low-lithium brine by separating magnesium and enriching lithium. A salt-lake brine is used as a raw material and is converted into halide salts through dehydration by evaporation and separation by crystallization; the halide salts are directly extracted using trialkyl phosphate or a mixture of trialkyl phosphate and monohydric alcohol, and an organic extraction phase as well as remaining halide salts are obtained after solid-liquid separation; reverse extraction is performed on the organic extraction phase to obtain a lithium-rich solution with a low magnesium-to-lithium ratio, and lithium carbonate is obtained after concentration and removal of magnesium by alkalization. The used solid-liquid extraction method is simple with no co-extraction agent used, and a solute distribution driving force is strong, unaffected by phase equilibrium of the brine extraction agent.

Abstract: One aspect of the disclosure relates to the use of derivatives of dichlorophenyl urea for treating cancers.

Abstract: The present invention relates to a SAPO-34 molecular sieve having both micropores and mesopores and synthesis method thereof. The mesopore diameter in the molecular sieve is in a range of 2-10 nm and the mesopore volume thereof is 0.03-0.3 cm3/g. Triethylamine is used as a template agent and the pore size modifiers are added to the synthesis gel at the same time in the synthesis process, thereby the prepared molecular sieve crystals have mesopore distribution besides micropores. The SAPO-34 molecular sieve synthesized in the present invention can be used as catalysts for conversion of oxygen-containing compounds to lower olefins.

Abstract: One aspect of the disclosure relates to the use of derivatives of dichlorophenyl urea for treating cancers.

Abstract: The present invention discloses a method, an application server and a system for network access, wherein, the method comprises: receiving a network address of a network to be accessed provided by a user via a client; obtaining a temporary account information of the network to be accessed corresponding to the network address according to the network address; logging on the network to be accessed via the temporary account information; and feeding a network page information after logging on the network to be accessed back to the client.

Abstract: One aspect of the disclosure relates to derivatives of aryl and heterocyclic ureido aryl and heterocyclic carboxamido isobutyric acids, dichlorophenyl urea, curcumin, and 1,3-diazetidine-2,4-dione, and pharmaceutical compositions thereof. The derivatives disclosed herein can modulate development of adipocytes and various cancer cells, including resistant cancer cells and cancer stem cells. Another aspect of the disclosure relates to the use of the derivatives and pharmaceutical compositions disclosed herein in treatment of obesity and various cancers.

Abstract: The present invention relates to a SAPO-34 molecular sieve having both micropores and mesopores and synthesis method thereof. The mesopore diameter in the molecular sieve is in a range of 2-10 nm and the mesopore volume thereof is 0.03-0.3 cm3/g. Triethylamine is used as a template agent and the pore size modifiers are added to the synthesis gel at the same time in the synthesis process, thereby the prepared molecular sieve crystals have mesopore distribution besides micropores. The SAPO-34 molecular sieve synthesized in the present invention can be used as catalysts for conversion of oxygen-containing compounds to lower olefins.

Abstract: The present invention relates to a SAPO-34 molecular sieve having both micropores and mesopores and synthesis method thereof. The mesopore diameter in the molecular sieve is in a range of 2-10 nm and the mesopore volume thereof is 0.03-0.3 cm3/g. Triethylamine is used as a template agent and the pore size modifiers are added to the synthesis gel at the same time in the synthesis process, thereby the prepared molecular sieve crystals have mesopore distribution besides micropores. The SAPO-34 molecular sieve synthesized in the present invention can be used as catalysts for conversion of oxygen-containing compounds to lower olefins.

Abstract: A molecular sieve and a molecular sieve catalyst containing a surface heat impregnated with a metal. The molecular sieve is heated in the presence of a metal containing solution at a temperature between 30° C. and 400° C. then separated from the metal containing solution. The molecular sieve and molecular sieve catalyst is used to make olefin from an oxygenate feedstock.